Cholangiocarcinoma (CC) is the second most common primary hepatic malignancy after
hepatocellular cancer. CC accounts for approximately 10%‐25% of all hepatobiliary …

Cholangiocarcinomas are rare biliary tract tumors that are often challenging to diagnose and
treat. Cholangiocarcinomas are generally categorized as intrahepatic or extrahepatic …

Background: Despite data suggesting a rising worldwide incidence, intrahepatic
cholangiocarcinoma (IHC) remains an uncommon disease. This study analyzes changes in …

Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to
diagnose, and is associated with a high mortality. The incidence of intrahepatic …

Abstract The Japanese Society of Gastroenterology first published evidence-based clinical
practice guidelines for cholelithiasis in 2010, followed by a revision in 2016. Currently, the …

Cholangiocarcinoma (CCA) is an epithelial can-cer originating from the bile ducts with
features of cholangiocyte differentiation. 1 CCA is the second most common primary hepatic …

(Cancer Sci 2010; 101: 579–585) Cholangiocarcinoma is relatively rare, but high incidence
rates have been reported in Eastern Asia, especially in Thailand. The etiology of this cancer …

Background & Aims: Intrahepatic and extrahepatic cholangiocarcinomas are rare and highly
malignant cancers of the bile duct. Although the incidence of extrahepatic …

This paper presents the first version of clinical practice guidelines for intrahepatic
cholangiocarcinoma (ICC) established by the Liver Cancer Study Group of Japan. These …

Several advances in diagnosis, treatment and palliation of cholangiocarcinoma (CC) have
occurred in the last decades. A multidisciplinary approach to this disease is therefore …